HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Amikacin pharmacokinetic/pharmacodynamic in intensive care unit: a prospective database

Abstract : Background: Aminoglycosides have a concentration-dependent therapeutic effect when peak serum concentration (C max) reaches eight to tenfold the minimal inhibitory concentration (MIC). With an amikacin MIC of 8 mg/L, the C max should be 64-80 mg/L. This objective is based on clinical breakpoints and not on measured MIC. This study aimed to assess the proportion of patients achieving the pharmacokinetic/pharmacodynamic (PK/PD) target C max /MIC ≥ 8 using the measured MIC in critically ill patients treated for documented Gram-negative bacilli (GNB) infections. Methods: Retrospective analysis from February 2016 to December 2017 of a prospective database conducted in 2 intensive care units (ICU). All patients with documented severe GNB infections treated with amikacin (single daily dose of 25 mg/kg of total body weight (TBW)) with both MIC and C max measurements at first day of treatment (D1) were included. Results are expressed in n (%) or median [min-max]. Results: 93 patients with 98 GNB-documented infections were included. The median C max was 55.2 mg/L [12.2-165.7] and the median MIC was 2 mg/L [0.19-16]. C max /MIC ratio ≥ 8 was achieved in 87 patients (88.8%) while a C max ≥ 64 mg/L was achieved in only 38 patients (38.7%). Overall probability of PK/PD target attainment was 93%. No correlation was found between C max /MIC ratio and clinical outcome at D8 and D28. Conclusion: According to PK/PD parameters observed in our study, single daily dose of amikacin 25 mg/kg of TBW appears to be sufficient in most critically ill patients treated for severe GNB infections.
Document type :
Journal articles
Complete list of metadata

Cited literature [26 references]  Display  Hide  Download

https://hal.univ-reunion.fr/hal-03003316
Contributor : Réunion Univ Connect in order to contact the contributor
Submitted on : Friday, November 13, 2020 - 10:42:50 AM
Last modification on : Thursday, April 7, 2022 - 1:58:24 PM
Long-term archiving on: : Sunday, February 14, 2021 - 6:30:08 PM

File

s13613-020-00685-5.pdf
Publication funded by an institution

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Citation

Elsa Logre, Maya Enser, Sébastien Tanaka, Marie Dubert, Aurore Claudinon, et al.. Amikacin pharmacokinetic/pharmacodynamic in intensive care unit: a prospective database. Annals of Intensive Care, SpringerOpen, 2020, 10, pp.75. ⟨10.1186/s13613-020-00685-5⟩. ⟨hal-03003316⟩

Share

Metrics

Record views

53

Files downloads

93